Form 8-K - Current report:
SEC Accession No. 0001437749-24-032999
Filing Date
2024-11-01
Accepted
2024-11-01 16:34:30
Documents
15
Period of Report
2024-10-30
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tlry20241101_8k.htm   iXBRL 8-K 27019
2 EXHIBIT 10.1 ex_741645.htm EX-10.1 43457
  Complete submission text file 0001437749-24-032999.txt   212390

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tlry-20241030.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlry-20241030_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlry-20241030_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlry-20241030_pre.xml EX-101.PRE 11584
17 EXTRACTED XBRL INSTANCE DOCUMENT tlry20241101_8k_htm.xml XML 2830
Mailing Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065
Business Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065 519.322.8800
Tilray Brands, Inc. (Filer) CIK: 0001731348 (see all company filings)

EIN.: 824310622 | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 001-38594 | Film No.: 241419533
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)